ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Boc-His(Boc)-Aib-Glu(OtBu)-Gly-OH
C31H50N6O11
682.8 g/mol
Pharmaceutical Intermediate

Boc-His(Boc)-Aib-Glu(OtBu)-Gly-OH

CAS1169630-31-2
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a pharmaceutical intermediate used in the manufacturing and supply of drug substances. It features a complex structure with multiple amide and ester groups, consistent with its role in research and production workflows.

pharmaceutical intermediateresearch compound for drug development

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Boc-His(Boc)-Aib-Glu(OtBu)-Gly-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.75

BOC-HIS(TRT)-AIB-GLU(OTBU)-GLY-OH

CAS1890228-73-5

pharmaceutical intermediate

ReferenceSame Category

(22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid

CAS1169630-40-3

pharmaceutical intermediate

ReferenceSame Category

Semaglutide intermediate P29

CAS1169630-82-3

pharmaceutical intermediate

ReferenceSame Category

3-chlorophthalic anhydride

CAS117-21-5

pharmaceutical intermediate

ReferenceSame Category

3-(tert-Butoxycarbonylaminomethyl)azetidine hydrochloride

CAS1170108-38-9

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

2-[[(2S)-2-[[2-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]imidazol-4-yl]propanoyl]amino]propanoyl]amino]-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]acetic acid

InChIKey

FNXPUMYXFQQETO-PMACEKPBSA-N

SMILES

CC(C)(C)OC(=O)CC[C@@H](C(=O)NCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC1=CN(C=N1)C(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

Synonyms (2)

—

Sourcing Boc-His(Boc)-Aib-Glu(OtBu)-Gly-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→